Tackling the Opioid Epidemic with Information & Innovation

Provider using tablet for prescription tracking

The opioid epidemic doesn’t discriminate, said Afton Wagner, senior manager, federal affairs & pharmacy initiatives at HIMSS. “What’s very alarming to everyone is that there’s really no indication that this epidemic is slowing down any time soon, as the death tolls for opioid overdoses continue to be on the rise.” In 2016, overdoses involving opioids took more than 42,000 lives in the U.S.

A 2017 letter from the Commission on Combating Drug Addiction and the Opioid Crisis urged the president to take action, stating that the death toll from opioid overdoses was “equal to September 11 every three weeks.” In October 2017, the president declared the opioid epidemic a national public health emergency.

Opioid Policy Webinars

Leveraging Health IT to Mitigate the Opioid Crisis: Policy Landscape and Steps Forward
Part 1 of 3: Listen to webinar
Part 2 of 3: July 30  |  Register or learn more
Part 3 of 3: August 27  |  Save the date

Analyzing Root Causes of the Opioid Epidemic

Though there’s no single cause for the public health crisis, it’s important to acknowledge key events that took place during the early to mid-1990s which helped spur the epidemic. The idea of pain as the “fifth vital sign” rapidly caught fire, timed poorly with the launch of an aggressive marketing campaign for a newly minted prescription pain medication. The new drug’s marketing campaign led doctors and patients to believe that this pain management medication was non-addictive. Though this was later determined to be misinformation, it wasn’t soon enough to curb the subsequent overprescribing, widespread diversion and misuse of these medications that built momentum for the full-fledged epidemic we’re seeing today.

The CDC reports that in 2015, enough opioids were prescribed to keep every American medicated around the clock for three weeks straight.

Source: National Vital Statistics System Mortality File














As we look at the graph above, we can see three distinct waves related to the increase in opioid overdose deaths. In Wave 1, we see prescription overdose deaths rising slowly and steadily from 1999 to 2016. Wave 2 displays a major increase of heroin overdose deaths in 2010, when America saw a pill problem turn into a heroin problem.

“During this time, heroin made its way from rural Mexico to small-town America,” Wagner explained. “Patients addicted to prescription opioids turned to heroin when the supply of the prescription medications needed to feed their addiction was not readily available.”

Wave 3 is where the U.S. currently stands with the quickly progressing epidemic. Beginning around 2013, a major increase was observed in drug overdoses involving synthetic opioids – particularly those involving illicitly manufactured fentanyl, which is more potent than heroin.

The dangers of these illicit substances has prompted the Drug Enforcement Administration to release recommendations for first-responders to proceed with increased caution, as minimal contact with these substances (such as skin exposure) can result in death. In addition to the Administration’s focus on combating the opioid crisis, the epidemic is also top of mind to federal government agencies. Specifically, the department of Health and Human Services (HHS) is committed to using expertise and resources from its agencies to combat the opioid epidemic and announced a five-point strategy in April 2017 for fighting the opioid crisis. HHS will be coordinating opioid epidemic efforts across agencies moving forward.

Awareness around the factors leading up to the epidemic, as well as understanding the following components as contributors, are truly key to understanding the growing wrath of this epidemic.

Innovating Approaches to Prescription Drug Monitoring

The opioid epidemic didn’t start with just one cause, which means only a multi-faceted approach will work in combating it. One resource helping empower providers with information during the public health epidemic includes Prescription Drug Monitoring Programs (PDMPs). PDMPs track prescription drug distribution, and many are specifically focused on tracking opioids, controlled substances and other drugs of concern with growing abuse and overdose rates.

Created in 2011, Nebraska’s PDMP is among the most innovative and patient-safety focused to date. In 2016, state legislation expanded the potential of their PDMP by allowing prescribers/dispensers to access the system at no cost, and in January 2018 mandated that all controlled substance prescriptions to be reported to PDMPs.

Unique in its approach, Nebraska’s PDMP is the first in the U.S. to track all prescription drug data rather than just controlled substances. This can not only help curb opioid overdose rates and identify things like overprescribing or ‘doctor shopping,’ but can also prevent deaths due to drug allergies or interactions. Nebraska is also the first state to operate their PDMP on a health information exchange platform.

Today, Nebraska has one of the lowest opioid-related overdose rates in the country. The state attributes its success to utilizing the PDMP first and foremost as a patient safety tool utilized by healthcare providers. With more data, physicians are empowered to provide better care and make better-informed decisions for all patients – ultimately driving better patient outcomes.

The Long Road Ahead

Though overdose deaths resulting from opioid use are still increasing, so are the amount of digital health resources available to healthcare professionals. As we’ve seen in Nebraska, increased innovation can mean improved outcomes for patients.

As covered in the 2017 Governors Letter to President’s Commission on Combating Drug Addiction & the Opioid Crisis, the first points of focus in fighting the epidemic include curbing the overprescribing of opioids and synthetic opioids supply, and increasing emphasis on recovery, as well as increased awareness of the epidemic as the result of a disease.

“There’s a lot of relapsing in opioid addiction as you might expect, so it’s important to have recovery support as we treat these addictions. It’s been noted that relapse rates for substance abuse disorders are similar to other diseases, like diabetes,” said Jim Douglas, former governor of Vermont, Governor’s Advisory Council of the Bipartisan Policy Center and co-chair, HIMSS State Advisory Roundtable.

As federal officials continue to offer more consistent messaging around opioid addiction as a disease requiring a public health approach based on science and evidence, hopefully stigma surrounding addiction will continue to subside and shed more light on the grave and deadly impact this epidemic has inflicted across multiple generations.

With widespread adoption of PDMPs and other patient safety tools designed to improve outcomes for the growing population of opioid addicted patients, hope remains for improved outcomes. Until then, we must continue fighting vigorously to protect the general public from the devastating impact of this public health crisis.